Recombinant Human Oncostatin M Reagent Market

Future Market Insights

Key Insight

The recombinant human oncostatin M reagent market is projected to grow from USD 116.9 million in 2025 to USD 276.8 million by 2035, at a CAGR of 9.0%. Purity＜95% will dominate with a 55.0% market share, while university will lead the application segment with a 60.0% share.

September 26, 2025

Anurag Sharma

250 Pages

Cite this Report

Recombinant Human Oncostatin M Reagent Market

https://www.futuremarketinsights.com/reports/recombinant-human-oncostatin-m-reagent-market

License

Buy Now

Summary ToC Companies

Key Players

Abcam plc
BD Biosciences
BPS Bioscience
Bio-Rad Laboratories
Bio-Techne
Elabscience
Enzo Biochem Inc
FUJIFILM Irvine Scientific
Prospec-Tany Technogene Ltd
Sino Biological,Inc
Thermo Fisher Scientific Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Recombinant Human Oncostatin M Reagent Market

Key Players

Similar Industry Reports